Michael F. Cannon Government should not purchase medicines for civilians. Period. The US Medicare and Medicaid programs illustrate why. Medicare...
Read moreWalter Olson I had missed the story from two weeks ago about what happened after (apparent) agents of the US...
Read moreColleen Hroncich “Just do it yourself,” Cammy Herrera’s husband told her. Cammy, a former public school teacher, had been searching...
Read morePatrick G. Eddington House Rep. Anna Paulina Luna (R‑FL). There are still some House members who understand that the Bill...
Read moreWalter Olson The House Judiciary Committee on April 28 released budget reconciliation language that would do a truly remarkable thing:...
Read moreChris Edwards Numerous American cities suffer from political corruption. New York City has had trouble for decades. Corruption is also...
Read moreChris Edwards I testified yesterday at a House hearing focused on low-income welfare programs, including housing and food programs. The...
Read moreAdam N. Michel President Trump has repeatedly suggested Congress should cut the corporate tax rate to 15 percent for “companies that make...
Read moreChris Edwards I testified to a House subcommittee yesterday about affordable housing. In particular, I discussed the low-income housing tax...
Read moreMichael F. Cannon New Congressional Budget Office (CBO) projections confirm the worst fears of inefficient health care providers and other...
Read moreDisclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.